Efficacy and safety of SGLT2 inhibitor empagliflozin in T2DM with established cardiovascular disease: a systematic review and meta-analysis of RCTs
SGLT2抑制剂恩格列净治疗合并心血管疾病的2型糖尿病患者的疗效和安全性:一项随机对照试验的系统评价和荟萃分析
期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000004512
Abunada, Omar; Hassan, Farhad; Kumar, Naresh; Kumar, Sunil; Majeed, Irfan; Batra, Kantesh; Kumar, Dheeraj; Deepika, Deepika; Turesh, Muskan; Ashraf, Taimoor; Hyder, Salman; Suresh, Keziah Nithiya; Kumar, Laksh; Kumar, Sumet; Kamlesh, Fnu; Yusuf, Salih Abdella